Arq, Inc. ARQ
Nasdaq · XNAS · stock · Miscellaneous Chemical Products · website · IPO 2004-10-14
Arq, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $120.3M | $109.0M | $99.2M | $103.0M | $100.3M |
| R&D expense | $7.3M | $4.0M | $3.3M | $2.1M | $400,000 |
| SG&A expense | $22.6M | $28.7M | $34.1M | — | — |
| Operating income | -$53.0M | -$2.0M | -$13.3M | -$12.1M | $4.9M |
| Interest expense | — | — | $3.0M | $336,000 | $1.5M |
| Income tax | $0 | -$164,000 | $153,000 | $209,000 | $15.7M |
| Net income | -$52.6M | -$5.1M | -$12.2M | -$8.9M | $60.4M |
| EPS (diluted) | $-1.27 | $-0.14 | $-0.42 | $-0.48 | $3.27 |
| Operating cash flow | -$2.7M | $10.5M | -$16.7M | -$6.1M | $26.0M |
| Cash & equivalents | $6.6M | $13.5M | $45.4M | $66.4M | $78.8M |
| Inventory | $15.9M | $19.3M | $19.7M | $17.8M | $7.8M |
| Total assets | $230.6M | $284.4M | $235.5M | $181.2M | $185.4M |
| Total liabilities | $62.6M | $67.1M | $57.1M | $41.2M | $38.1M |
| Shareholders' equity | $168.0M | $217.3M | $178.4M | $140.0M | $147.3M |
Source: SEC EDGAR filings · CIK 0001515156 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.